In a recent comprehensive integrated genomic study in MPM, The Cancer Genome Atlas Research Network found that epithelioid tumours display the highest expression of VISTA among all investigated cancers [122], suggesting that VISTA might be a potential therapeutic target in MPM. The gene discussed is VSIR; the disease is cancer.